3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
5
Gliosarcoma
2
Brain Neoplasms
2
Recurrence
1
Prostatic Neoplasms
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Metatropic dwarfism
1
Carcinoma, Non-Small-Cell Lung
1
Astrocytoma
1
Interventions
Darbepoetin alfa
2
piperine
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Whole-Body Irradiation
1
Urination
1
Therapeutics
1
Sucrose
1
Rituximab
1
Phenytoin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Mycophenolic Acid
1
Morphine
1
Methotrexate
1
Methadone
1
Metformin
1
KW-2478
1
Hsp90 inhibitor KU757
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Fentanyl
1
Fatty Acids, Omega-3
1
Epoetin Alfa
1
Early Intervention, Educational
1
Cyclosporine
1
Curcumin
1
Celecoxib
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Monoclonal Gammopathy of Undetermined Significance
×
Cilengitide
×
Clear all
No trials found.